Discover Arthrosamid
In the realm of osteoarthritis (OA) treatments, a groundbreaking development has arrived, offering new hope to those suffering from the discomfort and limitations of this common joint condition. Introducing Arthrosamid® – a non-degrading, intra-articular polyacrylamide hydrogel injection, specifically designed for the treatment of symptomatic knee osteoarthritis pain. Developed by Contura, Arthrosamid® is poised to revolutionize the management of knee OA, providing long-term pain relief and delaying the necessity for knee surgery.
Key Benefits of Arthrosamid® Injections
Arthrosamid® stands out in the treatment of knee osteoarthritis due to its unique composition and the benefits it offers, including:
- Enhanced Viscosity and Lubrication: The injection restores the natural viscosity within the synovial fluid, promoting increased lubrication. Its viscosupplement cushion effect helps in improving load sharing across the knee joint.
- Structural Stability and Tissue Integration: The hydrogel’s composition of 2.5% polyacrylamide provides structural stability without degrading, while its 97.5% water content facilitates the exchange of organic molecules/nutrients and seamless tissue integration.
- Proven Effectiveness: Clinical trials highlight its effectiveness, with an average of 80% of patients under the age of 70 experiencing a 50% improvement in WOMAC pain scores at the one-year follow-up. New data extending to three years post-treatment continue to demonstrate its significant capacity to reduce pain.
- Safety Profile: Over two decades of use for various indications, more than 800,000 syringes of Arthrosamid® have been safely implanted worldwide, showcasing an admirable safety profile. The treatment is well tolerated, with no serious adverse events reported and any device-related events being mild and transient.
A Significant Advancement in OA Treatment
Arthrosamid® represents a significant innovation in the treatment landscape of knee osteoarthritis. Its non-degrading formula offers a minimally invasive solution that stands apart from traditional injection treatments, providing safe, long-lasting relief from pain and stiffness and improving the overall quality of life for patients. With the ability to delay invasive knee surgery, Arthrosamid® not only alleviates immediate discomfort but also contributes to the long-term management of knee osteoarthritis, firmly positioning itself as a game-changer in the field.
Why Choose Arthrosamid®?
For arthritis sufferers seeking alternatives to traditional treatments and the inevitable path towards knee surgery, Arthrosamid® offers a new opportunity for pain relief. Its unique composition, combined with demonstrated clinical success and a strong safety profile, make it an attractive option for both doctors and patients.Its unique composition, combined with demonstrated clinical success and a strong safety profile, make it an attractive option for both doctors and patients.
By providing 6, 1ml injections that can be delivered for substantial relief and improved mobility, Arthrosamid® aligns with the needs of modern patients who prioritize minimally invasive treatments without compromising effectivenessArthrosamid® aligns with the needs of modern patients who prioritize minimally invasive treatments without compromising effectiveness.
Arthrosamid At Carter & George
If you are navigating the challenges of knee osteoarthritis, consider the innovative solution that Arthrosamid® presents. With proven results and a commitment to pioneering advancements in OA treatment, it’s time to explore how Arthrosamid® can support you in reclaiming your mobility and quality of life.
If you would like to discuss this option with our Sport and Exercise Medicine Consultant to find out if this could be the treatment for you, please email sophie@carterandgeorge.co.uk who will be able to organise this for you.
